Industry: Pharmaceutical Manufacturing
Summary:
Paper-based investigations, fragmented training records, and manual change control processes exposed a global pharma manufacturer to regulatory risk and delayed quality decisions across multiple sites. Meeting FDA and EMA requirements—especially 21 CFR Part 11—was increasingly difficult at scale. S3Connections implemented a fully compliant digital quality and compliance platform integrating investigations, CAPA, SOP change management, training, and audit trails. Standardized workflows, electronic signatures, and centralized visibility accelerated investigation closures, reduced audit findings, and provided inspection-ready compliance across 120+ countries.
